Welcome to plenary session.

I'm Dr. Vinay Prasad. I'm an associate professor at the University of California, San Francisco.

My interests are medicine, hematology, oncology, and health policy, and that's what you're going to get on this podcast.

This week, we got a great episode in store for you.

We've got an interview, and I think you're going to really like this.

But first, a plug.

If you like this podcast, check out the new website, www.

www. plenary session podcast.com.

We've got show notes, we've got trial summaries, we've got everything you could want on the website.

Follow us on Twitter at plenary underscore session.

Write a review for us on the iTunes store.

And become a supporter for this podcast on Patreon.

Patreon backers get access to the slides for presentations I give on plenary session. You also get a few bonus lectures. And with that, let's start the show.

I'm back in Plenary Session video edition, joined by Sven Olson, Sven Jammin Olson.

You go by sphematologist on Twitter. Is that right?

I should have just kept it Svengiman, Sven Jamin.

That was the old one, right? Spen Jamm.

Yeah, it was more, it was more catchy. Everyone seems to remember that one better.

Now you're the sphematologist.

Correct. I feel like I had to rebrand myself when I became a

faculty member. Well, we're waiting for our compatriot, Dr. Joseph Shatzel. But Sven Olson is a

hematologist, oncologist, assistant professor, and division chief of the dissection of hematology

...